Bill > HR6624

This bill, titled the Biological Intellectual Property Protection Act of 2025, aims to safeguard sensitive United States intellectual property and information related to synthetic biology by restricting its export to "foreign entities of concern," which are defined as government entities, individuals, or organizations subject to the jurisdiction of, or controlled by, countries identified as foreign countries of concern. Specifically, the bill amends the Export Control Reform Act of 2018 to require a license for the export, reexport, or in-country transfer of digital sequences of synthetic DNA or RNA, which are human- or AI-designed molecules that can replicate in living cells or are synthesized and can interact with naturally occurring molecules. This measure is proposed in response to concerns that countries like the People's Republic of China, through strategies like "military-civil fusion" and various national laws compelling cooperation with national security priorities, systematically seek to acquire sensitive U.S. data and intellectual property to advance their military, intelligence, and technological capabilities, posing a direct threat to U.S. national security. The bill acknowledges that exporting novel synthetic DNA and RNA sequences can reveal valuable insights into biotechnology research, making them susceptible to theft by adversaries, and therefore proposes this licensing requirement to control such exports, with an exception for information already covered by existing export administration regulations.

Military Affairs and Security

https://www.congress.gov/bill/119th-congress/house-bill/6624/all-info